Quanterix Corp.
(NASDAQ : QTRX)

( )
QTRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-1.66%141.840.7%$1149.36m
PFEPfizer Inc.
-1.74%43.000.9%$947.30m
MRKMerck & Co., Inc.
-1.98%83.550.6%$760.25m
ABBVAbbVie, Inc.
3.49%68.002.3%$716.46m
BMYBristol-Myers Squibb Company
-1.88%44.911.4%$600.36m
LLYEli Lilly and Company
-3.45%111.381.0%$464.12m
NVSNovartis AG Sponsored ADR
-1.23%91.230.2%$173.78m
AZNAstraZeneca PLC Sponsored ADR
-1.04%40.971.2%$102.89m
GSKGlaxoSmithKline plc Sponsored ADR
-1.21%40.140.2%$90.50m
SNYSanofi Sponsored ADR
-0.78%43.150.2%$85.20m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.53%50.910.1%$74.64m
LCILannett Company, Inc.
3.70%5.8936.6%$4.48m
AKTXAkari Therapeutics Plc Sponsored ADR
-3.37%2.011.6%$0.40m
EPIXESSA Pharma Inc
7.73%2.520.1%$0.01m

Company Profile

Quanterix Corp. is a life sciences company, which develops ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its Single Molecule Array (Simoa) technology platform uses single molecule measurements to access previously undetectable proteins. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Lexington, MA.